Nicolas Sévenet

5.6k total citations · 1 hit paper
51 papers, 3.1k citations indexed

About

Nicolas Sévenet is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Nicolas Sévenet has authored 51 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 13 papers in Oncology and 13 papers in Genetics. Recurrent topics in Nicolas Sévenet's work include Chromatin Remodeling and Cancer (11 papers), BRCA gene mutations in cancer (10 papers) and PI3K/AKT/mTOR signaling in cancer (9 papers). Nicolas Sévenet is often cited by papers focused on Chromatin Remodeling and Cancer (11 papers), BRCA gene mutations in cancer (10 papers) and PI3K/AKT/mTOR signaling in cancer (9 papers). Nicolas Sévenet collaborates with scholars based in France, United States and Germany. Nicolas Sévenet's co-authors include Olivier Delattre, Rupert Handgretinger, Marie-Françoise Rousseau-Merck, Isabella Versteege, Peter F. Ambros, Alain Aurias, Julian Lange, Daniel Amram, Pascale Schneider and Michel Longy and has published in prestigious journals such as Nature, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Nicolas Sévenet

50 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

1998 1.1k citations Isabella Versteege, Nicolas Sévenet et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicolas Sévenet France	20	2.3k	1.1k	575	454	329	51	3.1k
Roland P. Kuiper Netherlands	35	2.6k 1.1×	1.1k 1.0×	1.1k 1.9×	513 1.1×	1.1k 3.5×	123	5.4k
Richard C. Frank United States	21	1.1k 0.5×	616 0.6×	986 1.7×	495 1.1×	204 0.6×	50	2.4k
Norihiko Kawamata Japan	38	2.2k 1.0×	745 0.7×	1.4k 2.4×	314 0.7×	588 1.8×	96	4.0k
Michel Longy France	35	2.4k 1.0×	1.0k 0.9×	1.3k 2.3×	412 0.9×	864 2.6×	93	4.0k
Mats Ehinger Sweden	30	1.5k 0.7×	558 0.5×	847 1.5×	260 0.6×	267 0.8×	86	3.2k
Jeffrey Swensen United States	28	1.2k 0.5×	747 0.7×	1.3k 2.3×	663 1.5×	754 2.3×	87	3.1k
Nicolaus Friedrichs Germany	30	1.7k 0.7×	936 0.8×	945 1.6×	477 1.1×	595 1.8×	75	3.3k
Catherine Miquel France	22	755 0.3×	483 0.4×	654 1.1×	271 0.6×	286 0.9×	57	2.2k
Benjamin S. Braun United States	29	1.8k 0.8×	339 0.3×	615 1.1×	908 2.0×	257 0.8×	50	3.2k
Cristiana Bellan Italy	29	965 0.4×	769 0.7×	1.1k 1.9×	209 0.5×	459 1.4×	94	2.2k

Countries citing papers authored by Nicolas Sévenet

Since Specialization

Citations

This map shows the geographic impact of Nicolas Sévenet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Sévenet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Sévenet more than expected).

Fields of papers citing papers by Nicolas Sévenet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Sévenet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Sévenet. The network helps show where Nicolas Sévenet may publish in the future.

Co-authorship network of co-authors of Nicolas Sévenet

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Sévenet. A scholar is included among the top collaborators of Nicolas Sévenet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Sévenet. Nicolas Sévenet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bubien, Virginie, Nancy Uhrhammer, Maud Privat, et al.. (2023). Diagnosis of PTEN mosaicism: the relevance of additional tumor DNA sequencing. A case report and review of the literature. BMC Medical Genomics. 16(1). 166–166. 6 indexed citations

Jones, Natalie, Audrey Gros, Valérie Velasco, et al.. (2022). PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomas. Cancer Genetics. 264-265. 8–15. 3 indexed citations

Callens, Céline, Dominique Vaur, Isabelle Soubeyran, et al.. (2020). Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial. JNCI Journal of the National Cancer Institute. 113(7). 917–923. 26 indexed citations

Callens, Céline, Dominique Vaur, Isabelle Soubeyran, et al.. (2017). BRCA1&2 tumoral and germline status for ovarian cancer patients in first line setting within the PAOLA-01 trial. Annals of Oncology. 28. v332–v333. 1 indexed citations

Morgat, Clément, Gaëtan MacGrogan, Véronique Brouste, et al.. (2017). Expression of Gastrin-Releasing Peptide Receptor in Breast Cancer and Its Association with Pathologic, Biologic, and Clinical Parameters: A Study of 1,432 Primary Tumors. Journal of Nuclear Medicine. 58(9). 1401–1407. 84 indexed citations

Bubien, Virginie, Natalie Jones, Françoise Bonnet, et al.. (2017). Insertion of Alu elements at a PTEN hotspot in Cowden syndrome. European Journal of Human Genetics. 25(9). 1087–1091. 13 indexed citations

Jones, Natalie, et al.. (2015). La connaissance du statut de BRCA1 devrait-elle avoir un impact sur le choix d’un cytotoxique dans le cancer du sein ? Revue de la littérature. Bulletin du Cancer. 102(3). 245–255. 2 indexed citations

Italiano, Antoîne, Chun‐Liang Chen, Rachael Thomas, et al.. (2012). Alterations of the p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas. Cancer. 118(23). 5878–5887. 90 indexed citations

Bonnet, Françoise, Mickaël Guedj, Natalie Jones, et al.. (2012). An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis. BMC Medical Genomics. 5(1). 54–54. 16 indexed citations

10.

Isidor, Bertrand, Franck Bourdeaut, Ghislaine Plessis, et al.. (2012). Wilms’ tumor in patients with 9q22.3 microdeletion syndrome suggests a role for PTCH1 in nephroblastomas. European Journal of Human Genetics. 21(7). 784–787. 19 indexed citations

11.

Payen, Didier, Anne‐Claire Lukaszewicz, Valérie Faivre, et al.. (2008). Gene profiling in human blood leucocytes during recovery from septic shock. Intensive Care Medicine. 34(8). 1371–1376. 65 indexed citations

12.

Gallet, Marlène, et al.. (2006). Imatinib mesylate (Gleevec®) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity. European Journal of Pharmacology. 551(1-3). 27–33. 55 indexed citations

13.

Gallet, Marlène, Nicolas Sévenet, Claude Dupont, Michel Brazier, & Saı̈d Kamel. (2004). Breast cancer cell line MDA-MB 231 exerts a potent and direct anti-apoptotic effect on mature osteoclasts. Biochemical and Biophysical Research Communications. 319(2). 690–696. 14 indexed citations

14.

Vassal, Gilles, Jean‐Louis Merlin, Marie‐José Terrier‐Lacombe, et al.. (2003). In vivo antitumor activity of S16020, a topoisomerase II inhibitor, and doxorubicin against human brain tumor xenografts. Cancer Chemotherapy and Pharmacology. 51(5). 385–394. 15 indexed citations

15.

Grill, Jacques, Hervé Avet‐Loiseau, Arielle Lellouch‐Tubiana, et al.. (2002). Comparative genomic hybridization detects specific cytogenetic abnormalities in pediatric ependymomas and choroid plexus papillomas. Cancer Genetics and Cytogenetics. 136(2). 121–125. 36 indexed citations

16.

Melot, Thomas, Luce Dauphinot, Nicolas Sévenet, François Radvanyi, & Olivier Delattre. (2001). Characterization of a new brain‐specific isoform of the EWS oncoprotein. European Journal of Biochemistry. 268(12). 3483–3489. 18 indexed citations

17.

Schmitz, Ulrike, et al.. (2001). INI1 mutations in meningiomas at a potential hotspot in exon 9. British Journal of Cancer. 84(2). 199–201. 91 indexed citations

18.

Sévenet, Nicolas, Arielle Lellouch‐Tubiana, Deborah E. Schofield, et al.. (1999). Spectrum of hSNF5IINI1 Somatic Mutations in Human Cancer and Genotype-Phenotype Correlations. Human Molecular Genetics. 8(13). 2359–2368. 236 indexed citations

19.

Versteege, Isabella, Nicolas Sévenet, Julian Lange, et al.. (1998). Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature. 394(6689). 203–206. 1141 indexed citations breakdown →

20.

Melot, Thomas, et al.. (1997). Production and Characterization of Mouse Monoclonal Antibodies to Wild-Type and Oncogenic FLI-1 Proteins. Hybridoma. 16(5). 457–464. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact